Relationship between opium abuse and severity of depression in type 2 diabetic patients

Diabetes and Metabolism Journal

Volumn 36, Issue 2, 2012, Pages 157-162

  Zahra, Sepehrmanesh ^a   Hossein, Sarmast ^a   Ali, Kord Valeshabad ^b,c  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c National Elite Foundation   (Iran)

Author keywords

Depression; Diabetes mellitus; Opium

Indexed keywords

EID: 84864578460     PISSN: 22336079     EISSN: 22336087     Source Type: Journal    
DOI: 10.4093/dmj.2012.36.2.157     Document Type: Article

References (40)

1. Khamseh ME, Baradaran HR, Rajabali H. Depression and diabetes in Iranian patients: a comparative study. Int J Psychiatry Med 2007;37:81-6.
2. Nau DP, Aikens JE, Pacholski AM. Effects of gender and depression on oral medication adherence in persons with type 2 diabetes mellitus. Gend Med 2007;4:205-13.
3. Larijani B, Khoram Shahi Baiat M, Khalili Gorgani M, Bandarian F, Akhondzadeh S, Sadjadi SA. Association between depression and diabetes. German J Psychiatry 2004;7:62-5.
4. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. Harrison's principal of internal medicine. 15th ed. New York: McGrow-Hill; 2001.
5. Ahmadi J, Sharifi M, Mohagheghzadeh S, Dehbozorgi GR, Farrashbandi H, Moosavinasab M, Firoozabadi A, Pridmore S, Evren C, Busch S, Farash S. Pattern of cocaine and heroin abuse in a sample of Iranian population. German J Psychiatry 2005; 8:1-4.
6. Ahmadi J, Maharlooy N, Alishahi M. Substance abuse: prevalence in a sample of nursing students. J Clin Nurs 2004;13:60-4.
7. Shiri R, Hassani KF, Ansari M. Association between opium abuse and comorbidity in diabetic men. Am J Addict 2006;15: 468-72.
8. Gharagozlou H, Behin MT. Frequency of psychiatric symptoms among 150 opium addicts in Shiraz, Iran. Int J Addict 1979;14: 1145-9.
9. Kaplan H, Sadock B. Kaplan and Sadock's synopsis of psychiatry. 9th ed. Baltimore: Lippincott Williams & Wilkins; 2002.
10. Ahmadi J, Toobaee S, Kharras M, Radmehr M. Psychiatric disorders in opioid dependants. Int J Soc Psychiatry 2003;49:185-91.
11. Pavarin RM. Substance use and related problems: a study on the abuse of recreational and not recreational drugs in Northern Italy. Ann Ist Super Sanita 2006;42:477-84.
12. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000;160:3278-85.
13. Kivela SL, Pahkala K. Clinician-rated symptoms and signs of depression in aged Finns. Int J Soc Psychiatry 1988;34:274-84.
14. Kawakami N, Takatsuka N, Shimizu H, Ishibashi H. Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 1999;22:1071-6.
15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
16. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-71.
17. Othmer E, Othmer SC. The clinical interview using DSM-IVTR. Fundamentals. 1st ed. Vol. 1. Washington, DC: American Psychiatric Publishing; 2002.
18. The Expert Panel. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988;148:36-69.
19. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003;26 Suppl 1: S33-50.
20. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 2006;23:1165-73.
21. Katon WJ. The comorbidity of diabetes mellitus and depression. Am J Med 2008; 121(11 Suppl 2):S8-15.
22. Williams MM, Clouse RE, Lustman PJ. Treating depression to prevent diabetes and its complications: understanding depression as a medical risk factor. Clin Diabetes 2006;24:79-86.
23. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003;54:317-29.
24. Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006;49:837-45.
25. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Diez Roux AV, Lee HB, Lyketsos C. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008;299:2751-9.
26. Harris MD. Psychosocial aspects of diabetes with an emphasis on depression. Curr Diab Rep 2003;3:49-55.
27. Ludman EJ, Katon W, Russo J, Von Korff M, Simon G, Ciechanowski P, Lin E, Bush T, Walker E, Young B. Depression and diabetes symptom burden. Gen Hosp Psychiatry 2004;26:430-6.
28. Bryan CJ, Songer TJ, Brooks MM, Thase ME, Gaynes BN, Klinkman M, Rush AJ, Trivedi MH, Fava M, Wisniewski SR. A comparison of baseline sociodemographic and clinical characteristics between major depressive disorder patients with and without diabetes: a STAR*D report. J Affect Disord 2008; 108:113-20.
29. Ahmadi J, Pridmore S, Alimi A, Cheraghi A, Arad A, Parsaeyan H, Mohagheghzadeh MS, Kianpour M. Epidemiology of opium use in the general population. Am J Drug Alcohol Abuse 2007;33:483-91.
30. Goodman LS, Gilman A. The pharmacological basis of therapeutics. 7th ed. New York: McGraw Hill; 1985.
31. McIntyre RS, Mancini D, Eisfeld BS, Soczynska JK, Grupp L, Konarski JZ, Kennedy SH. Calculated bioavailable testosterone levels and depression in middle-aged men. Psychoneuroendocrinology 2006;31:1029-35.
32. Kanayama G, Amiaz R, Seidman S, Pope HG Jr. Testosterone supplementation for depressed men: current research and suggested treatment guidelines. Exp Clin Psychopharmacol 2007; 15:529-38.
33. Kumano H. Hormone replacement up-to-date. The effects of androgen replacement therapy on brain function. Clin Calcium 2007;17:1378-83.
34. Blatt SJ, Rounsaville B, Eyre SL, Wilber C. The psychodynamics of opiate addiction. J Nerv Ment Dis 1984;172:342-52.
35. Elson DF, Meredith M. Therapy for type 2 diabetes mellitus. WMJ 1998;97:49-54.
36. Karam GA, Reisi M, Kaseb AA, Khaksari M, Mohammadi A, Mahmoodi M. Effects of opium addiction on some serum factors in addicts with non-insulin-dependent diabetes mellitus. Addict Biol 2004;9:53-8.
37. Azod L, Rashidi M, Afkhami-Ardekani M, Kiani G, Khoshkam F. Effect of opium addiction on diabetes. Am J Drug Alcohol Abuse 2008;34:383-8.
38. D'Mello DA, Rooker GM. Refractory depression, cardiovascular risk factors, and leukoariosis. J Clin Psychiatry 1997;58:274.
39. Lishman WA. Organic psychiatry: the psychological consequences of cerebral disorder. 3rd ed. London: Blackwell Science; 1998.
40. Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE. Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med 1997;59:24-31.